
Preparing a quiet space
A substance-specific video result for Kratom searches that should be balanced with official NIDA and NCCIH sources before clinical conclusions are drawn.
Source Intelligence
Creator
American Kratom Association
Duration
1:07:04
Transcript
auto captioned
Audience
People in recovery, Loved ones
Recovery Pathway
Clinical education, Harm reduction
AI Summary
This source gives the Kratom query a dedicated video result, but the platform should rank official NIDA and NCCIH context beside it because it is stakeholder-hosted.
Key Takeaways
Transcript
Status
auto captioned
Public briefing metadata for kratom science and policy discussion.
Use with editorial balance because the source is a policy stakeholder, not a government publisher.
Chapters
0:00
Briefing context
Introduces the science and policy discussion.
18:00
Research perspectives
Discusses evidence gaps, use patterns, and dependence questions.
45:00
Policy implications
Explores public policy and consumer safety questions.
Related Knowledge
Kratom Research Topic
NIDA's research topic page for kratom, including reported uses, dependence questions, withdrawal, and the status of emerging evidence.
Kratom
NCCIH's kratom overview covers reported use, current research limits, safety concerns, addiction potential, withdrawal, and product contamination issues.
Kratom and 7-OH: What Clinicians Need to Know
A clinical podcast episode on kratom, 7-hydroxymitragynine, pharmacology, withdrawal, addiction potential, and treatment concerns.
AA Big Book Study: Recovery Science in Plain Language
Evidence-oriented metadata that grounds recovery support without replacing clinical advice.
AA Big Book Study: Harm Reduction Safety Check
Public-health metadata for safer planning, crisis boundaries, care options, and support before urgency.
Kratom Science Podcast 81: Dr. Kirsten Smith of NIDA Returns
A long-form podcast interview with Dr. Kirsten Smith discussing kratom research, dependence, policy, and emerging evidence.
What is Harm Reduction?
A concise NIDA explainer on harm reduction as a public health strategy for reducing risk and keeping people connected to care.
Medications for Opioid Use Disorder
A NIDA explainer on FDA-approved medications for opioid overdose, withdrawal, cravings, and opioid use disorder treatment.